{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "82706-026",
      "generic_name": "Oxymetazoline hydrochloride.",
      "labeler_name": "VIVUNT PHARMA LLC",
      "brand_name": "Sinus Severe Ultra Fine Mist",
      "active_ingredients": [
        {
          "name": "OXYMETAZOLINE HYDROCHLORIDE",
          "strength": ".5 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "82706-026-01",
          "description": "1 BOTTLE, SPRAY in 1 CARTON (82706-026-01)  / 15 mL in 1 BOTTLE, SPRAY",
          "marketing_start_date": "20260119",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "VIVUNT PHARMA LLC"
        ],
        "rxcui": [
          "1000990"
        ],
        "spl_set_id": [
          "48bf7422-38ef-d4b4-e063-6294a90aa3ab"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0850047780683"
        ],
        "unii": [
          "K89MJ0S5VY"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "AEROSOL, SPRAY",
      "spl_id": "48bf7422-38f0-d4b4-e063-6294a90aa3ab",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "NASAL"
      ],
      "marketing_start_date": "20260119",
      "product_id": "82706-026_48bf7422-38f0-d4b4-e063-6294a90aa3ab",
      "application_number": "M012",
      "brand_name_base": "Sinus Severe Ultra Fine Mist",
      "pharm_class": [
        "Imidazolines [CS]",
        "Increased Sympathetic Activity [PE]",
        "Vasoconstriction [PE]",
        "Vasoconstrictor [EPC]"
      ]
    }
  ]
}